Cited by 209Menopause: Health Impacts and TreatmentsBone health and osteoporosis researchEstrogen and related hormone effects

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.

CHRISTIANSEN, CLAUS, CHRISTENSEN, MERETE SANVIG, LARSEN, NIELS-ERIK, TRANSBØL, IB·1982·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jcem-55-6-1124

Open this paper in CoChat — free account

Abstract

Dose-response relationships of estrogen (E) on indices of calcium balance and bone activity were studied in normal early postmenopausal women. Calcium balance was estimated by changes in forearm bone mineral content, measured by photon absorptiometry. Bone activity was estimated by serum alkaline phosphatases (S-aPh), indicating bone formation, and by fasting urinary excretion of hydroxyproline (U-HyPro) and calcium (U-Ca), indicating bone resorption. A total of 92 female volunteers were randomized to 12 months' treatment with placebo or one of three different doses (high, medium, or low) of natural estrogens (17 beta-estradiol and estriol, 4/2, 2/1, and 1/0.5 mg, respectively), sequentially combined with the same dose (1 mg) of norethisterone acetate for 10 of the 28 cycle days. The trial was completed by 79 women. Bone mineral content declined by 2% (P less than 0.001) in the placebo group, remained constant in the low hormone group and increased by 0.8% (P less than 0.05) and 1.5% (P less than 0.01), respectively, in the medium and high hormone groups. S-aPh decreased gradually and equally by 20-25% in the three hormone groups and U-HyPro and U-Ca decreased by 30-40% during 1-yr hormone treatment, irrespective of dose. The decrease in these three indices occurred practically without exceptions. Compared to the values found in 48 normal premenopausal women the untreated postmenopausal women had increased values of S-aPh (P less than 0.001), U-HyPro (P less than 0.01), and U-Ca (P less than 0.001), and no pretreatment values were below the normal premenopausal range. After treatment the mean values of S-aPh and U-HyPro were slightly lower than the premenopausal mean values (P less than 0.01). These data strongly support the major importance of E deficiency for early postmenopausal bone loss, which is prevented by even a small substitution dose of E.

Integrity signals

Registry

Crossref · 10.1210/jcem-55-6-1124

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women
Recker, R. R., Saville, P. D., & Heaney, R. P. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-6-649 · Cited by 563
Menopausal changes in calcium balance performance
Heaney, R. P., Recker, R. R., & Omaha, P. D. S. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1983.tb07709.x · Cited by 531
Voluntary Medical Care Insurance in the United States
(1949) · JAMA · doi:10.1001/jama.1949.02900460063032 · Cited by 459
POST-MENOPAUSAL $OElig;STROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS A Case-control Study
HUTCHINSON, T. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90640-8 · Cited by 452
Menopausal changes in bone remodeling.
Heaney, R. P., Recker, R. R., & Saville, P. D. (1978) · PubMed · Cited by 435
Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.
Nachtigall, L. E., Nachtigall, R. H., Nachtigall, R. D., & Beckman, E. M. (1979) · PubMed · Cited by 374
Tetracycline double-labeling of iliac trabecular bone in 41 normal adults
Melsen, F., & Mosekilde, L. (1978) · Calcified Tissue International · doi:10.1007/bf02013242 · Cited by 232
A unified concept of osteoporosis
Heaney, R. P. (1965) · The American Journal of Medicine · doi:10.1016/0002-9343(65)90109-9 · Cited by 189
Bone remodeling and calcium metabolism: A correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease
Lauffenburger, T., Olah, A. J., Dambacher, M. A., Guncaga, J., Lentner, C., & HAAS, H. G. (1977) · Metabolism · doi:10.1016/0026-0495(77)90081-6 · Cited by 120
Long-term reproducibility of bone mineral content measurements
Christiansen, C. B., & Roödbro, P. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517709092636 · Cited by 113
Self-citation

Show all 13 references

Sorted by citations

Items 101–200 of 209

Effect of sequential and daily continuous hormone replacement therapy on indexes of mineral metabolism
Fuleihan, G. E. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.9.1904 · Cited by 26
Characterisation of the temporal sequence of osteoblast gene expression during estrogen‐induced osteogenesis in female mice
Plant, A., & Tobias, J. H. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1201 · Cited by 25
Differential associations for menopause and age in measures of vitamin K, osteocalcin, and bone density
Lukacs, J. L., Booth, S. L., Kleerekoper, M., Ansbacher, R., Rock, C. L., & Reame, N. E. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000227023.89062.43 · Cited by 25
Bone formation is not coupled to bone resorption in site‐specific manner in adult rats
Chow, J. W. M., Badve, S., & Chambers, T. J. (1993) · The Anatomical Record · doi:10.1002/ar.1092360210 · Cited by 25
Comparative metabolic study of percutaneous versus oral micronized 17β-oestradiol in replacement therapy
de Moustier, B. F., Conard, J., Guyene, T. T., Sitt, Y., Denys, I. B., Arnoux-Rouveyre, M., & Pelissier, C. (1989) · Maturitas · doi:10.1016/0378-5122(89)90024-8 · Cited by 25
Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants
Holland, E. F. N., Leather, A. T., & Studd, J. W. W. (1995) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1995.tb09101.x · Cited by 25
Increased Bone Morphogenetic Protein-6 Expression in Mouse Long Bones After Estrogen Administration
Plant, A., & Tobias, J. H. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.782 · Cited by 23
Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?
Birkenhäger, J. C., Erdtsieck, R. J., Zeelenberg, J., van Kuik, C., van Veen, L. C. P., Birkenhäger-Frenkel, D. H., Luiken, G. P. M., Kooy, P. P. M., Gerritsma, E. J., Mulder, P. G. H., et al. (1992) · Bone and Mineral · doi:10.1016/0169-6009(92)90811-q · Cited by 23
Casodex (a Nonsteroidal Antiandrogen) Reduces Cancellous, Endosteal, and Periosteal Bone Formation in Estrogen-Replete Female Rats
Lea, C. K., Kendall, N., & Flanagan, A. M. (1996) · Calcified Tissue International · doi:10.1007/bf02508647 · Cited by 22
Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities
Labrie, F., Labrie, C., BÉLANGER, A., Giguère, V., Simard, J., Mérand, Y., Gauthier, S., Luu-The, V., Candas, B., Martel, C., et al. (2001) · Advances in protein chemistry · doi:10.1016/s0065-3233(01)56009-x · Cited by 22
Building healthy bones throughout life: an evidence‐informed strategy to prevent osteoporosis in Australia
Ebeling, P. R., Daly, R. M., Kerr, D. A., & Kimlin, M. G. (2013) · The Medical Journal of Australia · doi:10.5694/mjao12.11363 · Cited by 22
3-Amino-1-hydroxypropylidine-1-bisphosphonate (AHPrBP) suppresses not only the induction of new, but also the persistence of existing bone-forming surfaces in rat cancellous bone
Tobias, J. H., Chow, J. W. M., & Chambers, T. J. (1993) · Bone · doi:10.1016/8756-3282(93)90083-m · Cited by 20
Intranasal Salmon Calcitonin
Clissold, S. P., Fitton, A., & Chrisp, P. (1991) · Drugs & Aging · doi:10.2165/00002512-199101050-00007 · Cited by 20
Does postmenopausal bone loss respond to estrogen replacement therapy independent of bone loss rate?
Christiansen, C., & Rødbro, P. (1983) · Calcified Tissue International · doi:10.1007/bf02405112 · Cited by 20
Self-citation
Serum Bone Gla Protein and Other Biochemical Estimates of Bone Turnover in Early Postmenopausal Women during Prophylactic Treatment for Osteoporosis
Pødenphant, J., Christiansen, C., Catherwood, B. D., & Deftos, L. J. (1985) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1985.tb06133.x · Cited by 20
Self-citation
Hormone Replacement Therapy in the Aged
Jacobs, S., & Hillard, T. (1996) · Drugs & Aging · doi:10.2165/00002512-199608030-00005 · Cited by 20
Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated With Gonadotropin-Releasing Hormone Agonist
Moghetti, P., Castello, R., Zamberlan, N., Rossini, M., Gatti, D., Negri, C., Tosi, F., Muggeo, M., & Adámi, S. (1999) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199909000-00020 · Cited by 19
Postmenopausal Osteoporosis
Silverberg, S. J., & Lindsay, R. (1987) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30881-1 · Cited by 19
Measurements of whole body retention of diphosphonate and other indices of bone metabolism in 125 normals: Dependency on age, sex and glomerular filtration
Hiyldstrup, L., McNair, P., JENSEN, G. F., Mogensen, N., & Transbøl, I. (1984) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518409083629 · Cited by 19
Self-citation
High-dose estrogen-induced osteogenesis in the mouse is partially suppressed by indomethacin
Samuels, A., Perry, M. J., & Tobias, J. H. (1999) · Bone · doi:10.1016/s8756-3282(99)00226-4 · Cited by 19
Bone mass as referent for urinary hydroxyproline excretion: Age and sex-related changes in 125 normals and in primary hyperparathyroidism
Hyldstrup, L., McNair, P., JENSEN, G. F., Nielsen, H. R., & Transbøl, I. (1984) · Calcified Tissue International · doi:10.1007/bf02405383 · Cited by 19
Self-citation
A comparison of microanatomic basis for coupling between bone formation and bone resorption in man and the rat
Chow, J. W. M., Badve, S., & Chambers, T. J. (1993) · Bone · doi:10.1016/8756-3282(93)90164-6 · Cited by 18
Androgens contribute to the stimulation of cancellous bone formation by ovarian hormones in female rats
Gallagher, A. C., Chambers, T. J., & Tobias, J. H. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.3.e407 · Cited by 18
Comparison of two hormone replacement regimens — influence on lipoproteins and bone mineral content
Hirvonen, E., Elliesen, J., & Schmidt-Gollwitzer, K. (1990) · Maturitas · doi:10.1016/0378-5122(90)90091-j · Cited by 18
Reprint of Are all estrogens the same?
Bennink, H. J. T. C. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.11.015 · Cited by 17
An alternative to hysterectomy? GnRH analogue combined with hormone replacement therapy
GANGAR, K. F., Stones, W. R., Saunders, D., Rogers, V., Rae, T., Cooper, S., & Beard, R. W. (1993) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1993.tb12980.x · Cited by 17
The effects of clodronate on increased bone turnover and bone loss due to ovariectomy in rats
Kippo, K., Hannuniemi, R., Virtamo, T., Laurén, L., Ikävalko, H., Kovanen, V., Österman, T., & Sellman, R. (1995) · Bone · doi:10.1016/8756-3282(95)00388-6 · Cited by 17
Prophylactic treatment for age-related bone loss in women
Christiansen, C. (1986) · Springer eBooks · doi:10.1007/978-94-009-4145-8_11 · Cited by 17
Self-citation
Clinical and metabolic effects of a pill containing 30 mcg ethinylestradiol plus 75 mcg gestodene
FIORETTI, P., Fruzzetti, F., Navalesi, R., Ricci, C., Miccoli, R., Cerri, M., & Melis, G. B. (1989) · Contraception · doi:10.1016/0010-7824(89)90069-3 · Cited by 17
Moderately High Consumption of Ethanol Suppresses Bone Resorption in Ovariectomized but not in Sexually Intact Adult Female Rats
Fanti, P., Monier‐Faugere, M., Geng, Z., Cohen, D. A., & Malluche, H. H. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb04266.x · Cited by 16
Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption
Lau, K. ‐. W., Wang, S. P., Linkhart, T. A., Demarest, K. T., & Baylink, D. J. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090515 · Cited by 16
Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates
al-Azzawi, F. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802296245 · Cited by 20
Relationship between bone mineral density and a 10-year risk for coronary artery disease in a healthy Korean population
Lee, H. T., Shin, J., Min, S. Y., Lim, Y., Kim, K. S., Kim, S. G., Kim, J. H., & Lim, H. K. (2014) · Coronary Artery Disease · doi:10.1097/mca.0000000000000165 · Cited by 15
The anabolic action of 17β-estradiol (E2) on rat trabecular bone is suppressed by (3-amino-1-hydroxypropylidene)-1-bisphosphonate (AHPrBP)
Abe, T., Chow, J. W. M., Lean, J. M., & Chambers, T. J. (1992) · Bone and Mineral · doi:10.1016/0169-6009(92)90841-z · Cited by 15
Post‐Menopausal Osteoporosis: A practical approach to its prevention
Notelovitz, M. (1986) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348609157053 · Cited by 15
The effects of the addition of nomegestrol acetate to post-menopausal oestrogen therapy
Fraser, D. I., PADWICK, M. L., Whitehead, M. I., WHITE, J. O., Ryder, T. A., & Pryse-Davies, J. (1989) · Maturitas · doi:10.1016/0378-5122(89)90117-5 · Cited by 14
Urinary calcium excretion in healthy adolescents
Seifert-Mclean, C. M., Cromer, B. A., Mosher, G. J., & Mahan, J. D. (1989) · Journal of Adolescent Health Care · doi:10.1016/0197-0070(89)90061-2 · Cited by 14
The treatment of osteoporosis
Melick, R. A. (1986) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1986.tb112348.x · Cited by 14
Endocrinological Status of Postmenopausal Osteoporosis
Devogelaer, C. N. D. D. J.-P. (1986) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00572-5 · Cited by 14
Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women
Johansen, J. S., Jensen, S. B., Riis, B. J., & Christiansen, C. (1990) · Metabolism · doi:10.1016/0026-0495(90)90082-n · Cited by 13
Self-citation
Acute effect of the intranasal administration of salmon calcitonin in osteoporotic women
Vega, E., González, D., Ghiringhelli, G., & Mautalén, C. (1989) · Bone and Mineral · doi:10.1016/0169-6009(89)90083-4 · Cited by 13
Effect of protein restriction on the messenger RNA contents of bone-matrix proteins, insulin-like growth factors and insulin-like growth factor binding proteins in femur of ovariectomized rats
Higashi, Y., Takenaka, A., Takahashi, S., & Noguchi, T. (1996) · British Journal Of Nutrition · doi:10.1079/bjn19960188 · Cited by 12
Comparison of the response of pelvic and proximal tibial cancellous bone in rat to ovariectomy with estrogen replacement
Hodsman, A. B., Kiesel, M., Fraher, L. J., Watson, P. H., & Stitt, L. (1998) · Bone · doi:10.1016/s8756-3282(98)00093-3 · Cited by 12
The effect of olpadronate in ovariectomized thyroxine-treated rats
Zeni, S. N., Acotto, C. G., & Mautalén, C. (1997) · Bone · doi:10.1016/s8756-3282(97)00146-4 · Cited by 11
Effect of administration and subsequent cessation of buserelin on cancellous bone of female rats
Tobias, J. H., Chambers, T. J., & Gallagher, A. C. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091211 · Cited by 10
The Direct and Indirect Effects of Estrogen on Bone Formation
Chambers, T. J. (1998) · Advances in organ biology · doi:10.1016/s1569-2590(08)60139-1 · Cited by 10
The Yeast Connection Meets Chronic Mucocutaneous Candidiasis
Nisker, J. A., & Maruncic, M. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603273141317 · Cited by 10
Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist
Zamberlan, N., Castello, R., Gatti, D., Rossini, M., Braga, V., Fracassi, E., & Adámi, S. (1997) · Osteoporosis International · doi:10.1007/bf01623688 · Cited by 10
Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?
Christiansen, C., & Rødbro, P. (1984) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1984.tb04789.x · Cited by 10
Self-citation
Serum osteocalcin levels and bone mineral density in ovariectomized rats
Camara, C., Zhou, L.-Y., & Yang, N. (2015) · Cited by 9
Interactions of medroxyprogesterone acetate with estrogen on the calcium-parathyroid axis in post-menopausal women
Minkoff, J. R., Young, G., Grant, B., & Marcus, R. (1986) · Maturitas · doi:10.1016/0378-5122(86)90006-x · Cited by 9
The progesterone antagonist, RU486 does not affect basal or estrogen-stimulated cancellous bone formation in the rat
Abe, T., Chow, J. W. M., Lean, J. M., & Chambers, T. J. (1992) · Bone and Mineral · doi:10.1016/0169-6009(92)90872-b · Cited by 9
Review
Cesnjaj, M., Stavljenić, A., & Vukičević, S. (1991) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1991.29.4.211 · Cited by 9
Hydroxyproline/creatinine ratios as estimates of bone resorption in early postmenopausal women. Fasting and 24-h urine samples compared
Pødenphant, J., Riis, B. J., Larsen, N., & Christiansen, C. (1986) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518609083698 · Cited by 9
Self-citation
Postmenopausal osteoporosis and estrogens
Saville, P. D. (1984) · Postgraduate Medicine · doi:10.1080/00325481.1984.11697938 · Cited by 9
Concentrations of Follicle-Stimulating Hormone Correlate with Alkaline Phosphatase and a Marker for Vitamin K Status in the Perimenopause
Lukacs, J. L., & Reame, N. E. (2000) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/15246090050147709 · Cited by 8
The effects of SERMs on the skeleton
Tobias, J. H. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03343617 · Cited by 8
Prevention of Osteoporosis
Ellerington, M. C., & Stevenson, J. C. (1992) · Drugs & Aging · doi:10.2165/00002512-199202060-00006 · Cited by 8
Post-menopausal bone loss: effects of oestrogens and progestogens. A review
Riis, B. J., & Christiansen, C. (1986) · Maturitas · doi:10.1016/0378-5122(86)90034-4 · Cited by 7
Self-citation
Periosteal microcirculatory action of chronic estrogen supplementation in osteoporotic rats challenged with tourniquet ischemia
Szabó, A., Hartmann, P., Varga, R., Jánvári, K., Lendvai, Z., Szalai, I., Gomez, I., Varga, G., Greksa, F., Németh, I., et al. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.11.004 · Cited by 7
Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
Riis, B. J., & Christiansen, C. (1984) · Maturitas · doi:10.1016/0378-5122(84)90066-5 · Cited by 7
Self-citation
The Effect of Sodium on Calcium Requirement
Nordin, B. E. C., & Need, A. G. (1994) · Springer eBooks · doi:10.1007/978-1-4757-9092-4_12 · Cited by 7
Changes in the bone and liver isoenzymes of alkaline phosphatase in postmenopausal women being treated with norethisterone
Deeny, M., FARISH, E., Tillman, J., Dagen, M., Hart, D. M., & Fletcher, C. D. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90295-1 · Cited by 7
The effect of a new sequential oestradiol valerate and levonorgestrel preparation on the bone mineral density of postmenopausal women
Holland, E. F. N., Leather, A. T., Studd, J. W. W., & GARNETT, T. J. (1993) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1993.tb15124.x · Cited by 6
Effects of three therapeutic regimens on postmenopausal bone loss in oophorectomized women
Luisetto, G., Bottega, F., Zangari, M., Tizian, L., Scalella, P., & Pozzuoli, A. (1996) · Current Therapeutic Research · doi:10.1016/s0011-393x(96)80017-8 · Cited by 6
Prevention of osteoporosis in ovariectomized mice by electroporational gene transfer of parathyroid hormone
Liu, B., Tang, J., Ji, J., & Gu, J. (2003) · Biotechnology Letters · doi:10.1023/b:bile.0000007079.13308.2f · Cited by 6
Bone Mineral Metabolism at the Menopause: Determinants and Markers
Katz, I. A., & Epstein, S. (1993) · E&M. Endocrinology and metabolism · doi:10.1007/978-1-4613-9272-9_10 · Cited by 5
Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study
FARISH, E., Barnes, J. F., Rankin, M., & Hart, D. M. (2003) · Climacteric · doi:10.1080/713605414 · Cited by 4
The management of an endocrine deficiency disease
Wren, B. G. (1985) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1985.tb133221.x · Cited by 4
Five-year changes in bone density, and their relationship to plasma estradiol and pretreatment bone density, in an older population of postmenopausal women using long-term estradiol implants
Vashisht, A., & Studd, J. W. W. (2003) · Gynecological Endocrinology · doi:10.1080/09513590312331290398 · Cited by 3
Intravaginal DHEA, by a strictly local action, exerts beneficial effects on both vaginal atrophy symptoms and sexual dysfunction
Labrie, F. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.064 · Cited by 3
Analysis of the Contribution of Dydrogesterone to Bone Turnover Changes in Postmenopausal Women Commencing Hormone Replacement Therapy1
Tobias, J. H., Clarke, S., Mitchell, K., Robins, S. P., Amer, H., & Fraser, W. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7321 · Cited by 3
Calcitonin, estradiol, and hydroxyproline as parameters in the early diagnosis of involutional osteoporosis
Ferr�ndez, L., Mart�n, M., & Fern�ndez, M. (1990) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/bf00453137 · Cited by 2
Drug-Induced Bone Disorders
Sweeney, B. L. (2005) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1385/bmm:3:1:075 · Cited by 2
Biochemical Changes in Postmenopausal Women Following a Muscle Fitness Program
Snow-Harter, C. (1987) · The Physician and Sportsmedicine · doi:10.1080/00913847.1987.11702057 · Cited by 2
Calcium-Regulating Hormones: General
ADAMS, P. H. (1988) · ILSI human nutrition reviews · doi:10.1007/978-1-4471-1437-6_4 · Cited by 2
Treatment of Osteoporosis in The Elderly
Nordin, B. E. C., Need, A. G., Horowitz, M., & Morris, H. A. (1994) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30320-3 · Cited by 2
Gonadal hormones
Stevenson, J. C. (1997) · Osteoporosis International · doi:10.1007/bf01674815 · Cited by 2
Der Sinn einer Hormonsubstitution im Klimakterium der Frau
Urdl, W., Auner, H., & Giuliani, A. (1996) · European surgery. Supplement/European surgery · doi:10.1007/bf02629266 · Cited by 1
Is FEV1 an indicator of low bone mineral density in adults? The Fifth Korea National Health and Nutrition Examination Survey
Lee, K. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-014-0595-5 · Cited by 1
Type 2 diabetes exacerbates bone loss in Native American women
Leyva, M. J. (2012) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University) · Cited by 1
Drug Evaluation Oncologic, Endocrine & Metabolic: Alendronate (Fosamax®): clinical utility in metabolic bone disease
Hayes, J., & Sambrook, P. N. (1996) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.5.12.1691 · Cited by 1
CALCIUM SUPPLEMENTS AND POSTMENOPAUSAL OSTEOPOROSIS
Stevenson, J., MacIntyre, I. M., & Nordin, B. E. C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90724-x · Cited by 1
The Influence of Formulation and Device Variables on the Intransasal Absorption of Salmon Calcitonin
Dua, R. (1995) · doi:10.23860/diss-dua-ramneik-1995 · Cited by 1
The Anabolic Action of Estrogen on Rat Bone
Chambers, T. J., Chow, J. W. M., Lean, J. M., & Tobias, J. H. (1994) · Springer eBooks · doi:10.1007/978-3-662-03043-1_2
Clinical Aspects of Osteoporosis
Kuhlencordt, F. (1987) · Springer eBooks · doi:10.1007/978-3-642-73346-8_1
Veränderungen im Knochenstoffwechsel und/oder an der Knochenmatrix
Freyschmidt, J. (1993) · Springer eBooks · doi:10.1007/978-3-662-09918-6_6
Bone mineral mass and bone turnover parameters in osteoporosis
Erdtsieck, R. J. (1996) · RePub (Erasmus University Rotterdam)
Microvascular reactions of normal and osteoporotic bones in response to surgical interventions
Greksa, F. (2013) · doi:10.14232/phd.1848
The Role of Hormone Replacement Therapy in the Prevention and Treatment of Osteoporosis
Ellerington, M. C., Whitehead, M. I., & Stevenson, J. C. (1994) · CPOBGYN. Clinical perspectives in obstetrics and gynecology · doi:10.1007/978-1-4612-4330-4_16
Topical Estrogens
Shapiro, I. S. (1988) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1988.tb01259.x
Late prevention of hip fractures with hormone replacement therapy
Stevenson, J. C. (1996) · Osteoporosis International · doi:10.1007/bf01623769
Les thérapeutiques médicamenteuses préventives de l'ostéoporose postménopausique
Chaouat, D., & Tsouderos, Y. (1993) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(05)81148-8
INFLUENCE OF ANDROSTENEDIONE ON SEDENTARY FEMALE RATS
Steele, J. (2001) · Lincoln (University of Nebraska)
Mineral Nutritional Values of Radish Leaves, as Influenced by Varying Irrigation Water Types
Ibrahim, A. A. (2016)
Calcium Intake Requirements Along the Life Cycle and Associated Factors
Rubio-Navarro, L., & Pérez-Torrero, E. (2014) · Current Nutrition & Food Science · doi:10.2174/1573401311666141208220631
The role of boron alone or in combination with estrogen or PTH in the treatment of postmenopausal osteoporosis in ovariectomized rats
Sheng, M. H. ‐. (1996) · VTechWorks (Virginia Tech)
Laboratory Investigations Effects of Estrogen Replacement on Insulin-like Growth Factor I Concentrations in Serum and Bone Tissue and on Interleukin 1 Secretion from Spleen Macrophages in Oophorectomized Rats
Sato, F., Ouchi, Y., Masuyama, A., Nakamura, T., Hosoi, T., Okamoto, Y., Sasaki, N., Shiraki, M., & Orimo, H. (1993)
Influência do polimorfismo da apolipoproteína E sobre a expressão gênica e a terapia de reposição hormonal e atorvastatina, em mulheres em pós-menopausa
Issa, M. H. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2018.tde-02022018-101833
Structural transition of lactoferrin upon interaction with estradiol as revealed by spectroscopic techniques: a molten globule state investigation
Moastajabodave, Z., Beigoli, S., Rad, A. S., Saberi, M. R., & Chamani, J. (2018) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-018-1409-9

Authors: CHRISTIANSEN, C., CHRISTENSEN, M. S., LARSEN, N.-E., & TRANSBØL, I.
Affiliations: University of Copenhagen (DK)
ORCID: CHRISTIANSEN, CLAUS
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 1982-12
Volume: 55
Issue: 6
Pages: 1124-1130
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jcem-55-6-1124
OpenAlex: W2059782675
Cited by: 209
References: 13
Citations by year: 2026: 1 · 2020: 2 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 4 · 2012: 2
FWCI: 4.88
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords: estrogen, bone metabolism, postmenopausal bone loss, estrogen dose-response, estradiol, estriol, norethisterone acetate, calcium balance, bone mineral content, bone formation, bone resorption, alkaline phosphatase, urinary hydroxyproline, urinary calcium, hormone replacement therapy
MeSH terms: Adult, Alkaline Phosphatase, Bone and Bones, Calcium, Dose-Response Relationship, Drug, Estrogens, Female, Humans, Hydroxyproline, Menopause, Middle Aged, Minerals, Phosphates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks